Vectors for transfer of the gene for thymidine kinase data

Interim results of GTII's brain tumor trial showed that five of eight patients, who all had failed conventional therapies, had measurable antitumor response with the gene therapy. Three of the five patients showing a positive response

Read the full 360 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE